Table 3.

Patient demographic

Patient	Age(y)	Gender	Handedness	Education (y)	Disease duration (y)	Levodopa equivalent dose (mg)	H&Y stage OFF Medication	H&Y stage ON Medication	UPDRS-III OFF Medication	UPDRS-III ON Medication	MoCA	AES	BDI-II	Electrode model	Contact analyzed
1	73	Male	Rightness	9	11	750	2.5	2	40	27	24	12	41	Medtronic 3387S	L1 (L0)
2	65	Female	Rightness	13.5	10	937.5	4	3	59	40	20	31	26	Medtronic 3387S	L0 (L1)
3	57	Male	Rightness	23	10	963	3	2	41	23	26	39	7	Medtronic 3387S	L1 (L0)
4	34	Male	Rightness	10	20	600	4	3	96	41	26	49	11	SceneRay 1210-30/40	L1 (L0)
5	48	Male	Rightness	11	5	1105	4	2	59	10	28	30	2	PINS L302	L1 (L0)
6	50	Male	Rightness	5	8	437.5	3	3	46	20	22	54	4	Medtronic 3387S	L1 (L0)
7	47	Male	Rightness	12	10	1150	2.5	2	53	18	26	61	5	Medtronic 3387S	L0 (L1)
8	52	Male	Rightness	8	9	800	2.5	2	41	24	26	32	14	PINS L302	L0 (L1)
9	68	Male	Rightness	7	5	300	3	2.5	45	31	24	39	10	Medtronic 3387S	L0 (L1)
10	68	Male	Rightness	11	12	450	2	2	73	34	29	47	7	Medtronic 3387S	L0 (L1)
11	51	Male	Rightness	19	9	525	2.5	2	53	21	26	37	27	Medtronic 3387S	L0 (L1)

UPDRS-III Unified Parkinson’s Disease Rating Scale: Part III Score, MoCA Montreal Cognitive Assessment Score, AES Apathy Evaluation Scale Score, BDI-II Beck Depression Inventory Score, Contact analyzed columned refer to the reference contact.